Radon Toxicity
How Should Patients Potentially Exposed to Increased Levels of Radon Be Treated and Managed?
Course: CB/WB1585
CE Original Date: June 1, 2010
CE Renewal Date: June 1, 2012
CE Expiration Date: June 1, 2014
Download Printer-Friendly version [PDF - 809 KB]
Previous Section | Next Section |
Learning Objective |
Upon completion of this section, you will be able to
|
Introduction |
With radon, the most important preventive action is to minimize exposure to it. This requires appropriate measurement of environmental radon levels in the patient’s home to determine whether the levels are 4 pCi/L or more. If radon levels are at 4 pCi/L or more, recommendations to abate the increased exposure risk may include having the patient remediate radon levels in his or her home (reduction and abatement) to background, outdoor ambient air levels. More information on measuring and abating radon is available in “Annex I” at the end of this case study. Patients potentially exposed to increased radon levels at home should have a clinical assessment. If clinical findings are positive, consider appropriate referrals. |
Care of the Patient Potentially Exposed to Increased Levels of Radon |
Clinical care is based on findings from the initial clinical assessment and the health care provider’s clinical judgment. If a patient already has a respiratory condition, consider further testing, referral to a specialist, or both. The following may increase the likelihood of the patient having a pulmonary malignancy:
Patient care based on the physician’s assessment may include further testing or, depending on the findings, additional referrals to an oncologist and chest surgeon. Initially, one or more of the following tests might be ordered:
If a primary lung cancer is detected, a metastatic workup (scans of the brain, liver, adrenals, and bones) might be indicated. Depending on histologic type, local extension into adjacent anatomical structures, presence of metastases, and the general health of the patient, treatment options may include surgical excision, radiation therapy, chemotherapy, and possibly immunotherapy. Again, specialist care and his or her recommended treatment plan should guide such treatment. Referral to a specialist with expertise and experience treating lung disease is reasonable, given positive findings from the initial clinical assessment. The patient should be apprised of the positive findings together with the reason for referral. |
Key Points |
|
Progress Check |
Previous Section | Next Section |